Product NDC: | 55390-309 |
Proprietary Name: | Ceftriaxone |
Non Proprietary Name: | Ceftriaxone |
Active Ingredient(s): | 250 mg/8mL & nbsp; Ceftriaxone |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-309 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065465 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090722 |
Package NDC: | 55390-309-10 |
Package Description: | 10 VIAL in 1 BOX (55390-309-10) > 8 mL in 1 VIAL |
NDC Code | 55390-309-10 |
Proprietary Name | Ceftriaxone |
Package Description | 10 VIAL in 1 BOX (55390-309-10) > 8 mL in 1 VIAL |
Product NDC | 55390-309 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ceftriaxone |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20090722 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | CEFTRIAXONE SODIUM |
Strength Number | 250 |
Strength Unit | mg/8mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |